Shanghai Henlius Biotech, Inc. (2696.HK)

HKD 40.35

(3.59%)

Total Debt Summary of Shanghai Henlius Biotech, Inc.

Shanghai Henlius Biotech, Inc.'s latest annual total debt in 2023 was 4.09 Billion CNY , up 11.31% from previous year.
Shanghai Henlius Biotech, Inc.'s latest quarterly total debt in 2024 Q2 was 3.79 Billion CNY , up 6.95% from previous quarter.
Shanghai Henlius Biotech, Inc. reported annual total debt of 3.67 Billion CNY in 2022, up 40.19% from previous year.
Shanghai Henlius Biotech, Inc. reported annual total debt of 2.62 Billion CNY in 2021, up 43.05% from previous year.
Shanghai Henlius Biotech, Inc. reported quarterly total debt of 3.79 Billion CNY for 2024 Q2, up 6.95% from previous quarter.
Shanghai Henlius Biotech, Inc. reported quarterly total debt of 3.85 Billion CNY for 2023 Q1, up 4.84% from previous quarter.

Annual Total Debt Chart of Shanghai Henlius Biotech, Inc. (2023 - 2017)

Historical Annual Total Debt of Shanghai Henlius Biotech, Inc. (2023 - 2017)

Year	Total Debt	Total Debt Growth
2023	4.09 Billion CNY	11.31%
2022	3.67 Billion CNY	40.19%
2021	2.62 Billion CNY	43.05%
2020	1.83 Billion CNY	200.89%
2019	609.38 Million CNY	15.41%
2018	528.01 Million CNY	-30.38%
2017	758.42 Million CNY	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	3.79 Billion CNY	-7.39%
2024 Q2	3.79 Billion CNY	6.95%
2023 Q1	3.85 Billion CNY	4.84%
2023 Q2	3.93 Billion CNY	2.11%
2023 Q4	4.09 Billion CNY	0.67%
2023 FY	4.09 Billion CNY	11.31%
2023 Q3	4.06 Billion CNY	3.29%
2022 Q2	3.59 Billion CNY	2.85%
2022 Q4	3.67 Billion CNY	0.0%
2022 Q3	- CNY	-100.0%
2022 FY	3.67 Billion CNY	40.19%
2022 Q1	3.49 Billion CNY	33.15%
2021 Q1	2.54 Billion CNY	38.75%
2021 FY	2.62 Billion CNY	43.05%
2021 Q4	2.62 Billion CNY	2.91%
2021 Q3	2.54 Billion CNY	-2.15%
2021 Q2	2.6 Billion CNY	2.39%
2020 Q2	685.31 Million CNY	7.59%
2020 FY	1.83 Billion CNY	200.89%
2020 Q4	1.83 Billion CNY	4.09%
2020 Q3	1.76 Billion CNY	157.05%
2020 Q1	636.98 Million CNY	11.39%
2019 FY	609.38 Million CNY	15.41%
2019 Q1	687.91 Million CNY	37.39%
2019 Q4	571.84 Million CNY	0.0%
2019 Q3	571.84 Million CNY	-29.61%
2019 Q2	812.36 Million CNY	18.09%
2018 Q3	500.7 Million CNY	0.0%
2018 FY	528.01 Million CNY	-30.38%
2018 Q4	500.7 Million CNY	0.0%
2018 Q1	- CNY	0.0%
2017 FY	758.42 Million CNY	0.0%

Peer Total Debt Comparison of Shanghai Henlius Biotech, Inc.

Name	Total Debt	Total Debt Difference
Uni-Bio Science Group Limited	52.86 Million HKD	-7642.166%
CK Life Sciences Int'l., (Holdings) Inc.	5.93 Billion HKD	30.99%